Biltmore Family Office’s Heron Therapeutics HRTX Stock Holding History

Biltmore Family Office’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$126K	Sell
2025 Q2	$210K	Hold
2025 Q1	$223K	Hold
2024 Q4	$155K	Buy
2023 Q4	–	Sell
2023 Q3	$16.9K	Hold
2023 Q2	$19.1K	Buy
2023 Q1	$24.6K	Buy